Analysis of Anti-inflammatory and Antioxidant Pathways in Lung Diseases by Haem Oxygenase-1 (HO-1) in Induced Sputum and Carbon Monoxide (CO) in Exhaled Air
This trial is active, not recruiting.
|Sponsor||Tel-Aviv Sourasky Medical Center|
|Start date||December 2009|
|End date||September 2010|
|Trial size||70 participants|
|Trial identifier||NCT01140685, TASMC-10-LF-669-CTIL|
This work will focus on the anti-inflammatory and antioxidant pathways in lung diseases by measuring HO-1 in induced sputum and CO in exhaled air in cases of four respiratory diseases, asthma, chronic obstructive pulmonary disease (COPD), occupational lung diseases (OLD) and interstitial lung disease (ILD).
|Observational model||case control|
exhaled CO levels
time frame: 2010-2011
Male or female participants at least 18 years old.
Inclusion Criteria: - Male and female - Ages >/= 18 years - Diagnosed with one or more lung diseases - Referred for sputum induction to the Pulmonary Laboratory in the Tel-Aviv Sourasky Medical Center
|Principal investigator||Elizabeth Fierman, PHD|
Call for more information